The VA is conducting a sources-sought/RFI to identify qualified sources capable of supplying nuclear medicine radiopharmaceuticals—18-FDG, F18 NaF, and bulk F-18 FDG—for the VA Loma Linda Healthcare System. The anticipated acquisition is a single-award, firm-fixed-price IDIQ with a base period from 12/15/2026 through 12/14/2027 and four option years through 12/14/2031. Deliveries would be to the Nuclear Medicine Section, Imaging Service, Main Hospital, 4th Floor, Room 4E15, with routine next-business-day and emergency same-day delivery requirements. Estimated annual quantities are 240 doses each of 18-FDG and F18 NaF and 4 bulk F-18 FDG units, with individual delivery orders limited to a $10,000 minimum and $350,000 maximum. The notice is for information and planning only and seeks capability, size-status, and pricing feedback from interested sources.